Further, several plant-based antioxidants and synthetic small molecular inhibitors have been shown to prevent IBD by inhibiting the NLRP3 inflammasome and expression of inflammatory markers such as IL-1β, IL-6, INF-γ, and IL-2 [130,137]. Here, NLRP3 is linked to inflammatory bowel disease.